Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Leiomyosarcoma × Blood Specimen Collection × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 94 Neoplasms 86 Lung Neoplasms 46 Colorectal Neoplasms 45 Prostatic Neoplasms 35 Carcinoma, Non-Small-Cell Lung 33 Melanoma 31 Pancreatic Neoplasms 30 Head and Neck Neoplasms 24 Neoplastic Cells, Circulating 22 Ovarian Neoplasms 21 Colonic Neoplasms 19 Multiple Myeloma 18 Sarcoma 16 Uterine Cervical Neoplasms 15 Neoplasm Metastasis 15 Leukemia, Myeloid, Acute 15 Glioma 15 Carcinoma, Hepatocellular 14 Esophageal Neoplasms 13 Squamous Cell Carcinoma of Head and Neck 12 Lymphoma 12 Glioblastoma 12 Endometrial Neoplasms 12 Leukemia 11 Kidney Neoplasms 11 Hematologic Neoplasms 11 Myelodysplastic Syndromes 10 Carcinoma, Renal Cell 10 Brain Neoplasms 9

Interventions

Gemcitabine 14 Docetaxel 8 Doxorubicin 7 Radiotherapy 6 Trabectedin 5 pazopanib 4 Sunitinib 3 Nivolumab 3 Dacarbazine 3 liposomal doxorubicin 2 eribulin 2 avelumab 2 Specimen Handling 2 Radiation Dose Hypofractionation 2 Letrozole 2 Ifosfamide 2 Bevacizumab 2 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 2 tremelimumab 1 temsirolimus 1 sotigalimab 1 selinexor 1 sargramostim 1 ribociclib 1 regorafenib 1 pembrolizumab 1 pegfilgrastim 1 niraparib 1 lenvatinib 1 lentiviral minigene vaccine of COVID-19 coronavirus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04925089 2026-02-17

Localized Leiomyosarcoma Biomarker Protocol

University of Michigan Rogel Cancer Center

Leiomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡